Technology only Ingenes has,
created by our science
We restore damaged reproductive cells and tissue with therapies that are not available at any other institute in Latin America. We also genetically analyze every embryo to transfer only the healthy ones. If you were told there are no options left with your own eggs, that your endometrium won't respond, or that donation is your only path, chances are no one offered you what we have.
We restore what others give up on
Proprietary technology developed at Ingenes to recover the function of eggs and the endometrium.
Ovagen™
Regenerates ovarian tissue with mesenchymal stem cells.
Who it's for: Women aged 38 to 45, low ovarian reserve, multiple IVF cycles that didn't work. Outcome: Women aged 42 with three prior failed IVF cycles have achieved pregnancy with their own eggs.
Endogen™
Restores damaged endometrium.
Who it's for: Thin endometrium (under 7 mm), implantation failures. Outcome: Endometriums of 4 mm have grown to 9 mm.
IVF MORE™
Mitochondrial egg restoration. The only one of its kind in Mexico.
Who it's for: Low egg quality. Outcome: Improves the egg's energy after fertilization.
Biocelk™
Mesenchymal stem cells delivered intravenously.
Who it's for: Complement before IVF or Ovagen™, longevity. Outcome: Reduces inflammation and improves mitochondrial function.
We transfer only genetically healthy embryos
We reduce the risk of inherited diseases and choose the embryo with the highest implantation potential.
PGT-A
Identifies embryos with the correct number of chromosomes.
Who it's for: Any IVF patient who wants to maximize their chances.
PGT-M
Detects inherited diseases in the embryo before transfer.
Who it's for: Carriers of genetic conditions.
Sex selection (Eligender™)
Identification of sex prior to transfer. Legal in Mexico.
Who it's for: Patients who wish to choose the sex. Prohibited in Europe.
We assess the molecular quality of every egg
Beyond genetics, the Implantation Score, developed by the Ingenes research team and published in the Journal of Ovarian Research, analyzes the molecular profile of the cells surrounding each egg to identify which ones have the highest implantation potential, information that visual assessment under a microscope could never provide.
Technology that is born at Ingenes
Ovagen™, Endogen™, IVF MORE™, and Biocelk™ were born at our own research and innovation center. Here we develop, validate, and publish the technologies that later reach our patients, through peer-reviewed research and world-class scientific collaborations.
We don't just apply science: we create it.
Maybe there is a way forward
If other clinics closed the door, an evaluation with our team can show you options with your own eggs and your own body.